185 related articles for article (PubMed ID: 36499676)
21. A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer.
Gupta S; Silveira DA; Piedade GPS; Ostrowski MP; Mombach JCM; Hashimoto RF
Noncoding RNA Res; 2024 Mar; 9(1):185-193. PubMed ID: 38125755
[TBL] [Abstract][Full Text] [Related]
22. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.
Kolesnikoff N; Attema JL; Roslan S; Bert AG; Schwarz QP; Gregory PA; Goodall GJ
J Biol Chem; 2014 Apr; 289(16):11194-11205. PubMed ID: 24627491
[TBL] [Abstract][Full Text] [Related]
23. Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLC.
Gohlke L; Alahdab A; Oberhofer A; Worf K; Holdenrieder S; Michaelis M; Cinatl J; Ritter CA
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834189
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-198-5p inhibits the migration and invasion of non-small lung cancer cells by targeting fucosyltransferase 8.
Wang S; Zhang X; Yang C; Xu S
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):955-967. PubMed ID: 31381176
[TBL] [Abstract][Full Text] [Related]
25. MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1.
Li J; Xia L; Zhou Z; Zuo Z; Xu C; Song H; Cai J
Arch Biochem Biophys; 2018 Feb; 640():53-60. PubMed ID: 29325758
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA LINC00657 induced by SP1 contributes to the non-small cell lung cancer progression through targeting miR-26b-5p/COMMD8 axis.
Zhang R; Niu Z; Pei H; Peng Z
J Cell Physiol; 2020 Apr; 235(4):3340-3349. PubMed ID: 31566716
[TBL] [Abstract][Full Text] [Related]
27. ING5 overexpression upregulates miR-34c-5p/Snail1 to inhibit EMT and invasion of lung cancer cells.
Yang J; Liu X; Sun Y; Zhang X; Zhao Y; Zhang H; Mei Q; Meng J; Zhang F; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):809-817. PubMed ID: 37249332
[TBL] [Abstract][Full Text] [Related]
28. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
29. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
[TBL] [Abstract][Full Text] [Related]
30. miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1.
Gao HX; Yan L; Li C; Zhao LM; Liu W
Mol Med Rep; 2016 Nov; 14(5):4135-4143. PubMed ID: 27666124
[TBL] [Abstract][Full Text] [Related]
31. Pirfenidone promotes the levels of exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells.
Liu J; Cao L; Li Y; Deng P; Pan P; Hu C; Yang H
Hum Cell; 2022 Nov; 35(6):1813-1823. PubMed ID: 36002606
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6.
Ge X; Jiang Y; Hu X; Yu X
Transpl Immunol; 2021 Dec; 69():101478. PubMed ID: 34607003
[TBL] [Abstract][Full Text] [Related]
33. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
35. Suppression of MGAT3 expression and the epithelial-mesenchymal transition of lung cancer cells by miR-188-5p.
Niu H; Qu A; Guan C
Biomed J; 2021 Dec; 44(6):678-685. PubMed ID: 35166206
[TBL] [Abstract][Full Text] [Related]
36. Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT.
Tièche CC; Peng RW; Dorn P; Froment L; Schmid RA; Marti TM
BMC Cancer; 2016 Feb; 16():125. PubMed ID: 26895954
[TBL] [Abstract][Full Text] [Related]
37. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
38. CircRNA SOD2 motivates non-small cell lungs cancer advancement with EMT via acting as microRNA-2355-5p's competing endogenous RNA to mediate calmodulin regulated spectrin associated proteins-2.
Lv C; Hu Y; Zhou X; Zhu Y; Wang J; Zhou F
Bioengineered; 2022 Mar; 13(3):5756-5768. PubMed ID: 35188072
[TBL] [Abstract][Full Text] [Related]
39. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
40. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
